Tech Company Financing Transactions

Glympse Bio Funding Round

Section 32, Arch Venture Partners and Catalio Capital Management participated in a $46.7 million Series B venture round for Glympse Bio. The financing was announced on 7/17/2020.

Transaction Overview

Company Name
Glympse Bio
Announced On
7/17/2020
Transaction Type
Venture Equity
Amount
$46,700,000
Round
Series B
Investors

Section 32 (Lead Investor) (Steven Kafka)

Arch Venture Partners

Catalio Capital Management

CRV

DNS Capital

Gilead Sciences

Greatpoint Ventures Innovation Fund

New Leaf Venture Partners

Polaris Partners (Amy Schulman)

Temasek Holdings (Cayce Denton)

Waterman Ventures

Proceeds Purpose
The proceeds from the financing will support continued development of Glympse's novel biosensor platform in Non-Alcoholic Steatohepatitis (NASH), a disease that impacts 16 million people in the U.S. and 100 million worldwide.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
35 Cambridgepark Dr. 100
Cambridge, MA 02140
USA
Phone
(617) 863-3636
Website
www.glympsebio.com
Email Address
[email protected]
Overview
Glympse Bio is pioneering an in vivo sensing technology dedicated to transforming disease monitoring. The company has built a product engine enabling rapid development of tunable and bioengineered activity sensors for multiple indications including fibrosis, cancer, immunology and infectious diseases.
Profile
Glympse Bio LinkedIn Company Profile
Social Media
Glympse Bio Company Twitter Account
Company News
Glympse Bio News
Facebook
Glympse Bio on Facebook
YouTube
Glympse Bio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Caroline Loew
  Caroline Loew LinkedIn Profile  Caroline Loew Twitter Account  Caroline Loew News  Caroline Loew on Facebook
Chief Scientific Officer
Wendy Winckler
  Wendy Winckler LinkedIn Profile  Wendy Winckler Twitter Account  Wendy Winckler News  Wendy Winckler on Facebook
Co-Founder
Sangeeta Bhatia
  Sangeeta Bhatia LinkedIn Profile  Sangeeta Bhatia Twitter Account  Sangeeta Bhatia News  Sangeeta Bhatia on Facebook
Co-Founder
Gabe Kwong
  Gabe Kwong LinkedIn Profile  Gabe Kwong Twitter Account  Gabe Kwong News  Gabe Kwong on Facebook
VP - Bus. Development
Tracey Dawson
  Tracey Dawson LinkedIn Profile  Tracey Dawson Twitter Account  Tracey Dawson News  Tracey Dawson on Facebook
VP - Finance
Martha Denyer
  Martha Denyer LinkedIn Profile  Martha Denyer Twitter Account  Martha Denyer News  Martha Denyer on Facebook
VP - Operations
Dhaval Gosalia
  Dhaval Gosalia LinkedIn Profile  Dhaval Gosalia Twitter Account  Dhaval Gosalia News  Dhaval Gosalia on Facebook

 

 

Browse more venture capital transactions:

Prev: 7/17/2020: August Bioservices venture capital transaction
Next: 7/17/2020: Hummingbird venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.